
    
      Subjects either must have previously completed NPSP558 Study CL1-11-040 (REPLACE) including
      24 weeks of active therapy and 4 weeks of follow-up to Week 28 prior to enrolling in this
      study or have enrolled in REPLACE and dropped out during optimization, but currently meet
      inclusion/exclusion criteria for REPLACE.
    
  